🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522904-26-00
Ongoing Phase I

Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis

2025-522904-26-00 · tracked via the Priya Life Science EU tracker
Sponsor
Genentech Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
22/04/2026
Enrollment target
17
Sites
Italy, Spain, France, Germany

Condition studied

Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephritis (LN)

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522904-26-00 on CTIS ↗ ← All trials in the EU